Cilostazol, um inibidor da fosfodiesterase III: perspectivas futuras na aterosclerose Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis

Cilostazol, um inibidor da fosfodiesterase III: perspectivas futuras na aterosclerose Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis

Bibliographic Details
Main Authors:	Marcelo Pereira da Rosa, Gislaine Verginia Baroni, Vera Lúcia Portal
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Cardiologia (SBC) 2006-11-01
Series:	Arquivos Brasileiros de Cardiologia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2006001800035

Similar Items

Contribuição na prevenção da isquemia cerebral pelo cilostazol, um inibidor da fosfodiesterase III: revisão de literatura Contribution to prevention of cerebral ischemia by cilostazol, a phosphodiesterase III inhibitor: a review
by: Marcelo Pereira da Rosa, et al.
Published: (2008-03-01)

Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions
by: Daniëlle M. Coenen, et al.
Published: (2021-08-01)

The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis
by: Minji Sohn, et al.
Published: (2024-02-01)

The role of cilostazol, a phosphodiesterase 3 inhibitor, on oocyte maturation and subsequent pregnancy in mice.
by: Min Li, et al.
Published: (2012-01-01)

Efficacy of cilostazol in canine bradyarrhythmia
by: Takahiro Ohmori, et al.
Published: (2022-08-01)

DESCRIPTION OF EFFECTIVENESS OF CILOSTAZOL AND ASPIRIN AS ADJUVANT OF DIABETIC FOOT WAGNER GRADE II AND III
by: Pandji Winata Nurikhwan, et al.
Published: (2014-09-01)

DESCRIPTION OF EFFECTIVENESS OF CILOSTAZOL AND ASPIRIN AS ADJUVANT OF DIABETIC FOOT WAGNER GRADE II AND III
by: Pandji Winata Nurikhwan, et al.
Published: (2014-09-01)

The use of cilostazol in the treatment of patients with obliterating atherosclerosis on the background of diabetes mellitus
by: S. E. Katorkin, et al.
Published: (2022-08-01)

THE LEVEL OF SEROTONIN IN PATIENTS WITH GENERALIZED ATHEROSCLEROSIS AND ITS DYNAMICS UNDER THE INFLUENCE OF CILOSTAZOL
by: Tatiana Motsak, et al.
Published: (2020-07-01)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2019-05-01)

INIBIDORES DAS FOSFODIESTERASES DOS NUCLEÓTIDOS CÍCLICOS NA TERAPÊUTICA FARMACOLÓGICA
by: Sandra Morgado, et al.
Published: (2012-06-01)

Cilostazol for the prevention of pneumonia: a systematic review
by: Hirotaka Nakashima, et al.
Published: (2018-04-01)

Effect of cilostazol on arteriovenous fistula in hemodialysis patients
by: Jae Wan Jeon, et al.
Published: (2021-11-01)

Effect of cilostazol on arteriovenous fistula in hemodialysis patients
by: Jae Wan Jeon, et al.
Published: (2021-11-01)

Safety and efficacy of cilostazol in the management of intermittent claudication
by: Yung-Wei Chi, et al.
Published: (2008-12-01)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLCâMS/MS
by: Nejal M. Bhatt, et al.
Published: (2015-02-01)

Inibidores da fosfodiesterase do tipo 5 e perda auditiva neurossensorial súbita
by: Monique Antunes de Souza Chelminski Barreto, et al.
Published: (2013-12-01)

Cilostazol: Several issues to be considered about the safety profile
by: Hiroshi Ito
Published: (2023-09-01)

Cilostazol: Several issues to be considered about the safety profile
by: Hiroshi Ito
Published: (2023-09-01)

5. THE EFFECT OF CILOSTAZOL TO ARTERIAL STIFFNESS IN THE HYPERTENSIVE PATIENT
by: Jin Oh Na, et al.
Published: (2009-10-01)

Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
by: Paulo Roberto da Silva Lima, et al.

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
by: Mazlum Sahin, et al.
Published: (2021-12-01)

Management of peripheral arterial disease in the elderly: focus on cilostazol
by: Travis M Falconer, et al.
Published: (2008-03-01)

THE FEATURES OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CHRONIC CORONARY SYNDROME ON THE BACKGROUND OF GENERALIZED ATHEROSCLEROSIS UNDER THE INFLUECE OF CILOSTAZOL
by: Tatiana Motsak
Published: (2020-11-01)

Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome
by: Masahiro Tsuji, et al.
Published: (2020-04-01)

Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
by: Joon Beom Park, et al.
Published: (2023-08-01)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
by: Sheu Jiunn-Jye, et al.
Published: (2012-08-01)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
by: George Galyfos, et al.
Published: (2017-09-01)

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers
by: Katrine Falkenberg, et al.
Published: (2018-08-01)

Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.
by: Ke Ke, et al.
Published: (2015-01-01)

Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation.
by: Yoshifumi Kawanabe, et al.
Published: (2012-01-01)

Effect of cilostazol in experimental model of degloving injuries in rat limbs
by: André Pazio, et al.
Published: (2018-04-01)

POS-569 EFFECT OF CILOSTAZOL ON ARTERIOVENOUS FISTULA IN HEMODIALYSIS PATIENTS
by: J.W. Jeon, et al.
Published: (2021-04-01)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
by: Leonard LL Yeo, et al.
Published: (2021-02-01)

Efeito cardioprotetor dos inibidores da Fosfodiesterase 5 em modelo de Diabetes Mellitus experimental
by: Gilson Nogueira Freitas, et al.
Published: (2021-11-01)

Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
by: Kawamori Ryuzo, et al.
Published: (2006-08-01)

Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice
by: Shuichi Yanai, et al.
Published: (2022-12-01)

Preparation and in-vitro evaluation of cilostazol self-emulsifying drug delivery system
by: Ali N. Wannas, et al.
Published: (2020-06-01)

Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
by: Kuang-Yi Tseng, et al.
Published: (2023-03-01)

Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations
by: Lu Wang, et al.
Published: (2023-11-01)